Research and Markets (http://www.researchandmarkets.com/research/x74n6m/breast_cancer)
has announced the addition of the "Breast
Cancer Drug Pathway Analyzer 2014" report to their offering.
There are today at least 532 targeted molecular therapies known to
affect more than 253 specific intracellular signaling pathways for the
treatment of breast cancer. The rational for this plethora of treatment
strategies is based on our increasing understanding of the 290 drug
targets that are included in this drug-pathway analyzing tool. No less
than 287 of these have been recorded with mutations and 49 drug targets
have mutations which have been causally implicated in cancer.
The continuous identification of drug targets and pathways that are
altered in cancer is not only crucial for our understanding of cancer
biology, but also to search for new targets for early diagnosis and
improved treatment designs. Consequently, it has never before been as
important to rapidly translate systems biology of disease and
therapeutics to actionable pipeline decisions to ensure that the optimal
market conditions exist by the time a candidate drug is commercialized.
You Use this Analyzer Tool in Breast Cancer to:
For more information visit http://www.researchandmarkets.com/research/x74n6m/breast_cancer
[ Back To NFVZone's Homepage ]